Mylan Plaintiffs Make New Bid For Treble Damages

By Jacqueline Bell (November 5, 2007, 12:00 AM EST) -- In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court to triple damages against Mylan and two drug ingredient supplier defendants, citing details from a separate case....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as